153 related articles for article (PubMed ID: 36269032)
1. A clinical herbal prescription Gu-Shu-Kang capsule exerted beneficial effects on the musculoskeletal system of dexamethasone-treated mice by acting on tissue IGF-1 signalling pathway.
Li XL; Wang L; He MC; Li WX; Zhang JL; Fu YF; Zhang Y
Pharm Biol; 2022 Dec; 60(1):2098-2109. PubMed ID: 36269032
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 reverses the osteogenic inhibitory effect of dexamethasone on BMP9-induced osteogenic differentiation in mouse embryonic fibroblasts via PI3K/AKT/COX-2 pathway.
Jiang HT; Ran CC; Liao YP; Zhu JH; Wang H; Deng R; Nie M; He BC; Deng ZL
J Steroid Biochem Mol Biol; 2019 Jul; 191():105363. PubMed ID: 31018166
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
[TBL] [Abstract][Full Text] [Related]
4. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.
Yin HN; Chai JK; Yu YM; Shen CA; Wu YQ; Yao YM; Liu H; Liang LM; Tompkins RG; Sheng ZY
J Trauma; 2009 Apr; 66(4):1083-90. PubMed ID: 19359918
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
6. Psoralea corylifolia L. seed extract attenuates dexamethasone-induced muscle atrophy in mice by inhibition of oxidative stress and inflammation.
Seo E; Truong CS; Jun HS
J Ethnopharmacol; 2022 Oct; 296():115490. PubMed ID: 35728709
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1/2 signalling pathway.
Wang BY; Hsiao AW; Shiu HT; Wong N; Wang AY; Lee CW; Lee OK; Lee WY
Stem Cell Res Ther; 2023 Aug; 14(1):195. PubMed ID: 37542297
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
9. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
[TBL] [Abstract][Full Text] [Related]
10. Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone.
Fappi A; Neves JC; Sanches LN; Massaroto E Silva PV; Sikusawa GY; Brandão TPC; Chadi G; Zanoteli E
Cells; 2019 May; 8(5):. PubMed ID: 31052442
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Schisandrin A, A Bioactive Component of
Yeon M; Choi H; Jun HS
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32354126
[TBL] [Abstract][Full Text] [Related]
12. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice.
Pellegrino MA; D'Antona G; Bortolotto S; Boschi F; Pastoris O; Bottinelli R; Polla B; Reggiani C
Exp Physiol; 2004 Jan; 89(1):89-100. PubMed ID: 15109214
[TBL] [Abstract][Full Text] [Related]
13. Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats.
Schakman O; Kalista S; Bertrand L; Lause P; Verniers J; Ketelslegers JM; Thissen JP
Endocrinology; 2008 Aug; 149(8):3900-8. PubMed ID: 18467435
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D/Vitamin D Receptor Signaling Attenuates Skeletal Muscle Atrophy by Suppressing Renin-Angiotensin System.
Li WX; Qin XH; Poon CC; Wong MS; Feng R; Wang J; Lin FH; Sun YL; Liu SF; Wang YJ; Zhang Y
J Bone Miner Res; 2022 Jan; 37(1):121-136. PubMed ID: 34490953
[TBL] [Abstract][Full Text] [Related]
15. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
16. Zhuanggu Zhitong Capsule alleviates osteosarcopenia in rats by up-regulating PI3K/Akt/Bcl2 signaling pathway.
Ma J; Ye M; Li Y; Chai S; Huang H; Lian X; Huang H
Biomed Pharmacother; 2021 Oct; 142():111939. PubMed ID: 34311171
[TBL] [Abstract][Full Text] [Related]
17. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
18. Codonopsis lanceolata and its active component Tangshenoside I ameliorate skeletal muscle atrophy via regulating the PI3K/Akt and SIRT1/PGC-1α pathways.
Kim TY; Park KT; Choung SY
Phytomedicine; 2022 Jun; 100():154058. PubMed ID: 35349834
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
20. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction.
Feng L; Li B; Xi Y; Cai M; Tian Z
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C164-C176. PubMed ID: 34852207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
